ECE1 and amyloidosis: Indeed, PKCε has been associated with the activation of endothelin converting enzyme 1 (ECE-1) [150], one of the main enzymes involved in amyloid β degradation and amyloid plaque reduction [153,154], rendering PKCε activation and overexpression as effective methods to reduce amyloid pathology [155,156].